The first Sage Therapeutics trade was made in Q1 2015.
Since then Jim Simons bought shares five more times and sold shares on eight occasions. The investor completely sold their stake between Q3 2022 and Q4 2022.
Avg closing price
Price range
Sold -12.7 Thousand shares
Q4 2022
Avg closing price
$38.19
Price range
$32.20
-
$43.61
Sold 70.7% shares (-30.7 Thousand shares)
Q3 2022
Avg closing price
$38.65
Price range
$32.28
-
$43.27
New holding (+43.4 Thousand shares)
Q2 2022
Avg closing price
$33.52
Price range
$27.52
-
$37.99
Sold -286 Thousand shares
Q3 2020
Avg closing price
$50.68
Price range
$41.13
-
$62.45
Sold 61.7% shares (-461 Thousand shares)
Q2 2020
Avg closing price
$36.29
Price range
$25.95
-
$43.15
Increased shares by 575.6% (+637 Thousand shares)
Q1 2020
Avg closing price
$57.91
Price range
$26.15
-
$77.24
New holding (+111 Thousand shares)
Q4 2019
Avg closing price
$123.02
Price range
$60.18
-
$154.77
Sold -2.8 Thousand shares
Q4 2018
Avg closing price
$114.44
Price range
$81.94
-
$139.71
Sold 98.3% shares (-164 Thousand shares)
Q3 2018
Avg closing price
$154.35
Price range
$138.11
-
$169.04
Sold 42.9% shares (-125 Thousand shares)
Q2 2018
Avg closing price
$156.99
Price range
$140.36
-
$175.76
Increased shares by 1173.4% (+269 Thousand shares)
Q1 2018